WO2001076605A1 - Preparations a base de minoxidil - Google Patents
Preparations a base de minoxidil Download PDFInfo
- Publication number
- WO2001076605A1 WO2001076605A1 PCT/JP2001/002951 JP0102951W WO0176605A1 WO 2001076605 A1 WO2001076605 A1 WO 2001076605A1 JP 0102951 W JP0102951 W JP 0102951W WO 0176605 A1 WO0176605 A1 WO 0176605A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- minoxidil
- containing composition
- antioxidant
- composition according
- ginger
- Prior art date
Links
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 title claims abstract description 39
- 229960003632 minoxidil Drugs 0.000 title claims abstract description 39
- 238000002360 preparation method Methods 0.000 title abstract description 4
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 18
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 14
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 claims abstract description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 3
- CIWBSHSKHKDKBQ-DUZGATOHSA-N D-araboascorbic acid Natural products OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 claims abstract description 3
- 235000010350 erythorbic acid Nutrition 0.000 claims abstract description 3
- 239000004318 erythorbic acid Substances 0.000 claims abstract description 3
- 229940026239 isoascorbic acid Drugs 0.000 claims abstract description 3
- 239000000203 mixture Substances 0.000 claims description 50
- 238000004040 coloring Methods 0.000 claims description 19
- 235000010354 butylated hydroxytoluene Nutrition 0.000 claims description 11
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 claims description 10
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 10
- 235000008397 ginger Nutrition 0.000 claims description 10
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 claims description 6
- -1 alphathioglycerin Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 239000000284 extract Substances 0.000 claims description 5
- 150000005846 sugar alcohols Polymers 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 4
- 230000002265 prevention Effects 0.000 claims description 4
- YHMYGUUIMTVXNW-UHFFFAOYSA-N 1,3-dihydrobenzimidazole-2-thione Chemical compound C1=CC=C2NC(S)=NC2=C1 YHMYGUUIMTVXNW-UHFFFAOYSA-N 0.000 claims description 3
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims description 3
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 claims description 3
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 claims description 3
- YYVFXSYQSOZCOQ-UHFFFAOYSA-N Oxyquinoline sulfate Chemical compound [O-]S([O-])(=O)=O.C1=C[NH+]=C2C(O)=CC=CC2=C1.C1=C[NH+]=C2C(O)=CC=CC2=C1 YYVFXSYQSOZCOQ-UHFFFAOYSA-N 0.000 claims description 3
- 239000002202 Polyethylene glycol Substances 0.000 claims description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 3
- 235000010385 ascorbyl palmitate Nutrition 0.000 claims description 3
- VZFDRQUWHOVFCA-UHFFFAOYSA-L disodium;2-sulfanylbutanedioate Chemical compound [Na+].[Na+].[O-]C(=O)CC(S)C([O-])=O VZFDRQUWHOVFCA-UHFFFAOYSA-L 0.000 claims description 3
- 229960001257 oxyquinoline sulfate Drugs 0.000 claims description 3
- 229920001223 polyethylene glycol Polymers 0.000 claims description 3
- 229910052700 potassium Inorganic materials 0.000 claims description 3
- 239000011591 potassium Substances 0.000 claims description 3
- 239000000473 propyl gallate Substances 0.000 claims description 3
- 235000010388 propyl gallate Nutrition 0.000 claims description 3
- 229940075579 propyl gallate Drugs 0.000 claims description 3
- GNBVPFITFYNRCN-UHFFFAOYSA-M sodium thioglycolate Chemical compound [Na+].[O-]C(=O)CS GNBVPFITFYNRCN-UHFFFAOYSA-M 0.000 claims description 3
- 229940046307 sodium thioglycolate Drugs 0.000 claims description 3
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims description 2
- 241000147041 Guaiacum officinale Species 0.000 claims description 2
- 239000002310 Isopropyl citrate Substances 0.000 claims description 2
- 238000002845 discoloration Methods 0.000 claims description 2
- 229940091561 guaiac Drugs 0.000 claims description 2
- 235000019300 isopropyl citrate Nutrition 0.000 claims description 2
- SKHXHUZZFVMERR-UHFFFAOYSA-L isopropyl citrate Chemical compound CC(C)OC(=O)CC(O)(C([O-])=O)CC([O-])=O SKHXHUZZFVMERR-UHFFFAOYSA-L 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 229940083466 soybean lecithin Drugs 0.000 claims description 2
- 235000008694 Humulus lupulus Nutrition 0.000 claims 2
- 244000170916 Paeonia officinalis Species 0.000 claims 2
- 235000006484 Paeonia officinalis Nutrition 0.000 claims 2
- 235000005733 Raphanus sativus var niger Nutrition 0.000 claims 2
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 claims 2
- 240000001970 Raphanus sativus var. sativus Species 0.000 claims 2
- 244000273928 Zingiber officinale Species 0.000 claims 2
- PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 claims 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- DOIRQSBPFJWKBE-UHFFFAOYSA-N phthalic acid di-n-butyl ester Natural products CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 claims 1
- 239000008347 soybean phospholipid Substances 0.000 claims 1
- 241000894007 species Species 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 28
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 18
- 241000234314 Zingiber Species 0.000 description 18
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 12
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 11
- 235000019441 ethanol Nutrition 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 239000008213 purified water Substances 0.000 description 9
- 238000003756 stirring Methods 0.000 description 7
- 229940058015 1,3-butylene glycol Drugs 0.000 description 6
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 6
- 235000019437 butane-1,3-diol Nutrition 0.000 description 6
- 235000011007 phosphoric acid Nutrition 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- UWIULCYKVGIOPW-UHFFFAOYSA-N Glycolone Natural products CCOC1=C(CC=CC)C(=O)N(C)c2c(O)cccc12 UWIULCYKVGIOPW-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 229960004217 benzyl alcohol Drugs 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000012669 liquid formulation Substances 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- PPKPKFIWDXDAGC-IHWYPQMZSA-N (z)-1,2-dichloroprop-1-ene Chemical compound C\C(Cl)=C\Cl PPKPKFIWDXDAGC-IHWYPQMZSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- LZFZQYNTEZSWCP-UHFFFAOYSA-N 2,6-dibutyl-4-methylphenol Chemical compound CCCCC1=CC(C)=CC(CCCC)=C1O LZFZQYNTEZSWCP-UHFFFAOYSA-N 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 229940124532 absorption promoter Drugs 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- UTMTYYKGLQURCK-UHFFFAOYSA-N butane-1,3-diol;propane-1,2,3-triol Chemical compound CC(O)CCO.OCC(O)CO UTMTYYKGLQURCK-UHFFFAOYSA-N 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 235000011167 hydrochloric acid Nutrition 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- ZFSLODLOARCGLH-UHFFFAOYSA-N isocyanuric acid Chemical compound OC1=NC(O)=NC(O)=N1 ZFSLODLOARCGLH-UHFFFAOYSA-N 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000011344 liquid material Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4966—Triazines or their condensed derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
Definitions
- the present invention relates to a minoxidil-containing composition that prevents coloring over time.
- Minoxidil is a component that is expected as an external hair restorer because of its hair restorer effect.
- An object of the present invention is to prevent coloring of a composition containing minoxidil. Disclosure of the invention
- a colored screening ingredient to a liquid formulation by adding an antioxidant such as dibutylhydroxytoluene.
- an antioxidant such as dibutylhydroxytoluene can be used for a liquid formulation containing minoxidil.
- the present inventors have found that the addition of an oxidizing agent hardly contributes to the prevention of coloring, or enhances rather than prevents coloring.
- the present invention is a minoxidil-containing composition containing an antioxidant and having a pH of 5.5 to 7.0.
- the present invention is also a minoxidil-containing composition containing diptylhydroxytoluene or butylhydroxyanisole and having a pH of 5.5 to 7.0.
- the present invention is also a method for preventing discoloration of a minoxidil-containing composition, wherein an antioxidant is added to the composition and the pH is adjusted to 5.5 to 7.0.
- the antioxidants used in the present invention include dibutylhydroxytoluene, butylhydroxyanisole, erythorbic acid, EDTA-2Na, isopropyl citrate, propyl gallate, guaiac acid, alphathioglycerin, dichlor From potassium isocyanurate, 2,6-di-butyl-4-methylphenol, soybean lecithin, sodium thioglycolate, sodium thiomalate, ascorbyl palmitate, 2-mercaptobenzimidazole, oxyquinoline sulfate One or two selected from the group described below are preferred.
- Crude drug extracts can also be used as antioxidants, especially flea, ginger, ginger, ginger, ginger, ginger, ginger, ginger, ginger, ginger, ginger ginger, ginger ginger, ginger ginger, ginger ginger, ginger ginger, ginger ginger, ginger ginger, ginger ginger, ginger ginger, ginger ginger, ginger ginger, ginger ginger, ginger ginger, ginger ginger, ginger ginger, ginger ginger, ginger ginger, ginger ginger, ginger ginger, ginger ginger, ginger ginger, ginger ginger, ginger ginger, ginger ginger, ginger ginger, ginger ginger.
- an alcohol having 2 to 4 carbon atoms eg, ethanol, propylene glycol, 1,3-butylene glycol, glycerin, etc.
- a mixed solvent thereof eg., ethanol, propylene glycol, 1,3-butylene glycol, glycerin, etc.
- the compounding amount of the antioxidant in the present composition is preferably from 0.05 to 0.5 part by mass, more preferably from 0.01 to 0.5 part by mass, per 1 part by mass of minoxidil.
- coloring may be enhanced even when the pH is in the range of 5.5 to 7.0 when a sufficient amount is not added.
- the pH of the composition of the present invention is preferably 5.5 or more, and more preferably 5.7 or more, since lowering the pH lowers the coloring prevention effect.
- pH is preferably 7.0 or less, more preferably 6.3 or less, from the viewpoint of the solubility of minoxidil.
- the pH of the composition of the present invention can be adjusted using a pH adjusting agent that is commonly used.
- a pH adjusting agent that is commonly used.
- organic acids such as citric acid, malic acid and lactic acid, phosphoric acid, hydrochloric acid, Inorganic acids such as sulfuric acid can be mentioned.
- the concentration of minoxidil is preferably from 1 to 10% by mass, more preferably from 3 to 6% by mass of the whole composition.
- a polyhydric alcohol as a solvent.
- Polyhydric alcohols include propylene glycol, dipropylene glycol, 1,3-butylene glycol glycerin, hexylene glycolone, and polyethylene glycol are preferred, and 1,3-butylene glycol is more preferred.
- the blending amount of the polyhydric alcohol is preferably 1 to 50 parts by mass per 1 part by mass of minoxidil.
- composition of the present invention is not particularly limited, and can be any of lotions, aerosols, genoles, and the like. Can be prepared by any suitable method.
- composition of the present invention may contain, if necessary, a solubilizer (fatty acid ester, polyhydric alcohol fatty acid ester, medium-chain fatty acid glyceride, vegetable oil, alkyl glyceryl ether), surfactant (nonionic surfactant) , Lecithin derivatives, polymer emulsifiers), emulsion stabilizers, absorption promoters and the like.
- a solubilizer fatty acid ester, polyhydric alcohol fatty acid ester, medium-chain fatty acid glyceride, vegetable oil, alkyl glyceryl ether
- surfactant nonionic surfactant
- Lecithin derivatives emulsifiers
- emulsion stabilizers emulsion stabilizers
- absorption promoters emulsion stabilizers and the like.
- ⁇ ⁇ ⁇ ⁇ was measured with a glass electrode: ⁇ was measured after 5 minutes for 5 mL of the preparation using a ⁇ meter (manufactured by Toa Denpa Kogyo).
- a lotion-type composition was prepared.
- the pH of the composition was 6.0.
- Minoxidil 5 g, propylene glycol 52 g, ethanol 25 g, dibutylhydroxytoluene 0.5 g, phosphoric acid 0.3 mL are added, the total volume is made up to 100 mL with purified water, and the mixture is stirred and dissolved to give a lotion type.
- the pH of the composition was 6.0.
- Minoxidil (5 g), propylene glycol (52 g), and ethanol (25 g) were added, and the total amount was adjusted to 10 OmL with purified water, followed by stirring and dissolution to prepare a lotion-type composition.
- the pH of the composition was 8.7.
- the appearance was evaluated according to the following criteria.
- Comparative Example 1 coloring was recognized, and it was judged that there was a problem with the merchantability. However, in the case of the yarns of Examples 1 to 4, no coloring was observed, or slight coloring was observed. It was judged that there was no problem as a product.
- Example 5 Each of the compositions of Example 5 and Comparative Examples 2 to 4 was filled in a pet container, and 50. .
- the absorbance (420 nm) of the sample stored for 1 month at was measured using an absorption altimeter (manufactured by Beckman).
- Comparative Example 2 and Comparative Example 3 show that the minoxidil yarn composition further enhances coloring by decreasing the pH. Further, the results of Comparative Example 4 show that the addition of BHT enhances the coloring rather than preventing the coloring. On the other hand, in Example 5, a better coloring prevention effect was obtained than in any of the comparative examples.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Priority Applications (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01919789A EP1273299B1 (en) | 2000-04-07 | 2001-04-05 | Minoxidil-containing preparations |
| AT01919789T ATE306925T1 (de) | 2000-04-07 | 2001-04-05 | Minoxidil enthaltende zubereitung |
| US10/240,856 US20030157046A1 (en) | 2000-04-07 | 2001-04-05 | Minoxidil-containing preparations |
| AU46839/01A AU778783B2 (en) | 2000-04-07 | 2001-04-05 | Minoxidil-containing preparations |
| DE60114171T DE60114171T2 (de) | 2000-04-07 | 2001-04-05 | Minoxidil enthaltende zubereitung |
| NZ521733A NZ521733A (en) | 2000-04-07 | 2001-04-05 | Minoxidil-containing preparations |
| CA002405429A CA2405429C (en) | 2000-04-07 | 2001-04-05 | Minoxidil-containing preparation |
| BR0109847-0A BR0109847A (pt) | 2000-04-07 | 2001-04-05 | Composição contendo minoxidila, e, método para impedir a coloração da mesma |
| HU0301124A HUP0301124A2 (hu) | 2000-04-07 | 2001-04-05 | Elszíneződésre nem hajlamos. minoxidil-tartalmú kompozíció és eljárás minoxidiltartalmú kompozíció elszíneződésének megakadályozására |
| JP2002102373A JP4796260B2 (ja) | 2001-04-05 | 2002-04-04 | ミノキシジル含有製剤 |
| HK03108884A HK1056510A1 (en) | 2000-04-07 | 2003-12-05 | Minoxidil-containing preparations |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000-107028 | 2000-04-07 | ||
| JP2000107028A JP4780429B2 (ja) | 2000-04-07 | 2000-04-07 | ミノキシジル含有製剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2001076605A1 true WO2001076605A1 (fr) | 2001-10-18 |
Family
ID=18620086
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2001/002951 WO2001076605A1 (fr) | 2000-04-07 | 2001-04-05 | Preparations a base de minoxidil |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1273299B1 (es) |
| JP (1) | JP4780429B2 (es) |
| KR (1) | KR100740393B1 (es) |
| CN (1) | CN1279914C (es) |
| AT (1) | ATE306925T1 (es) |
| AU (1) | AU778783B2 (es) |
| BR (1) | BR0109847A (es) |
| CA (1) | CA2405429C (es) |
| DE (1) | DE60114171T2 (es) |
| DK (1) | DK1273299T3 (es) |
| ES (1) | ES2250374T3 (es) |
| HK (1) | HK1056510A1 (es) |
| HU (1) | HUP0301124A2 (es) |
| NZ (1) | NZ521733A (es) |
| RU (1) | RU2275914C2 (es) |
| TW (1) | TWI239842B (es) |
| WO (1) | WO2001076605A1 (es) |
| ZA (1) | ZA200207960B (es) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6946120B2 (en) | 1998-04-22 | 2005-09-20 | Connetics Australia Pty. Ltd. | Pharmaceutical composition |
| US8026238B2 (en) | 1997-10-17 | 2011-09-27 | Stiefel Research Australia, Pty Ltd | Topical antifungal composition |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5785353B2 (ja) * | 2004-02-27 | 2015-09-30 | 大正製薬株式会社 | 眼科用剤 |
| TW200534875A (en) * | 2004-04-23 | 2005-11-01 | Lonza Ag | Personal care compositions and concentrates for making the same |
| JP2006022091A (ja) * | 2004-06-09 | 2006-01-26 | Dai Ichi Seiyaku Co Ltd | 育毛用組成物 |
| JP5040060B2 (ja) * | 2004-10-14 | 2012-10-03 | 大正製薬株式会社 | メチオニン配合内服液剤 |
| AU2007335379B2 (en) * | 2006-12-20 | 2012-06-14 | Taisho Pharmaceutical Co., Ltd. | Prophylactic or therapeutic agent for alopecia |
| US20090175810A1 (en) | 2008-01-03 | 2009-07-09 | Gareth Winckle | Compositions and methods for treating diseases of the nail |
| JP5286999B2 (ja) * | 2008-07-10 | 2013-09-11 | 大正製薬株式会社 | ミノキシジル含有液剤 |
| JP2012504135A (ja) | 2008-09-27 | 2012-02-16 | ジャイナ ファーマシューティカルズ，インコーポレーテッド | 経口適用および局所適用のための脂質系薬学的調製物、ならびにそれらの組成物、方法、および使用 |
| US8470833B2 (en) | 2009-12-15 | 2013-06-25 | Mcneil-Ppc, Inc. | Hair growth and/or regrowth compositions |
| US8039494B1 (en) | 2010-07-08 | 2011-10-18 | Dow Pharmaceutical Sciences, Inc. | Compositions and methods for treating diseases of the nail |
| EP2952194B1 (en) * | 2013-01-31 | 2018-06-27 | Fujifilm Corporation | Emulsion composition |
| JP6199066B2 (ja) * | 2013-04-24 | 2017-09-20 | ロート製薬株式会社 | ミノキシジル含有外用組成物 |
| KR101580119B1 (ko) * | 2013-04-29 | 2015-12-29 | 한국유나이티드제약 주식회사 | 쓴맛이 차폐된 황련 추출물을 포함하는 경구투여용 제제 |
| MY179756A (en) | 2013-10-03 | 2020-11-12 | Dow Pharmaceutical Sciences | Stabilized efinaconazole formulations |
| CN105848719A (zh) | 2013-11-22 | 2016-08-10 | 道尔医药科学公司 | 抗感染的方法、组合物和装置 |
| JP6736889B2 (ja) * | 2015-01-23 | 2020-08-05 | 大正製薬株式会社 | 外用組成物 |
| JP6528194B2 (ja) * | 2015-02-06 | 2019-06-12 | ダイヤ製薬株式会社 | ミノキシジル含有外用液剤および外用液剤の製造方法 |
| JP6052686B2 (ja) * | 2015-02-06 | 2016-12-27 | ダイヤ製薬株式会社 | 外用液剤 |
| JP6825354B2 (ja) * | 2015-12-29 | 2021-02-03 | 大正製薬株式会社 | 外用組成物 |
| JP7346010B2 (ja) * | 2016-09-15 | 2023-09-19 | 大正製薬株式会社 | 外用組成物 |
| KR102000217B1 (ko) * | 2017-08-08 | 2019-07-15 | 에스씨엠생명과학 주식회사 | Cxcl1 단백질 및 미녹시딜을 유효성분으로 포함하는 탈모 예방 또는 치료용 약학적 조성물 |
| JP2017206558A (ja) * | 2017-08-22 | 2017-11-24 | ロート製薬株式会社 | ミノキシジル含有外用組成物 |
| JP2020023467A (ja) * | 2018-01-19 | 2020-02-13 | ロート製薬株式会社 | 外用製剤、液切れ性を改善する方法、および、液切れ性改善剤 |
| JP7304463B2 (ja) * | 2018-01-29 | 2023-07-06 | 富士化学工業株式会社 | ミノキシジル含有外用組成物 |
| JP2019014764A (ja) * | 2018-11-06 | 2019-01-31 | ロート製薬株式会社 | ミノキシジル含有外用組成物 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH03176413A (ja) * | 1989-12-05 | 1991-07-31 | Ichimaru Pharcos Co Ltd | 植物由来抽出成分からなるフケ菌発育阻害剤を含有する皮膚・頭皮・頭髪用化粧料 |
| JPH09188620A (ja) * | 1996-01-05 | 1997-07-22 | Taisho Pharmaceut Co Ltd | ヒノキチオール含有組成物 |
| JPH11349451A (ja) * | 1998-06-08 | 1999-12-21 | Taisho Pharmaceut Co Ltd | 育毛剤 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2601359B1 (fr) * | 1986-07-09 | 1988-10-28 | Cird | Nouveaux derives bicycliques naphtaleniques, leur procede de preparation et leur utilisation en medecine humaine et veterinaire et en cosmetique. |
| FR2621912B1 (fr) * | 1987-10-16 | 1990-03-02 | Oreal | Nouveaux derives du norbornane, leur procede de preparation et compositions cosmetique et medicamenteuse les contenant |
| DE68917946T2 (de) * | 1988-01-29 | 1995-01-05 | Peter H Proctor | Haarwachstumanregung mit Nitroxyd und anderen Radikalen. |
| FR2641184B1 (fr) * | 1988-12-30 | 1991-04-05 | Oreal | Composition pour induire et stimuler la croissance des cheveux et/ou freiner leur chute, a base de derives de pyrimidine et de filtres solaires |
| FR2756561B1 (fr) * | 1996-12-04 | 1999-01-08 | Cird Galderma | Composes heteroaryles, compositions pharmaceutiques et cosmetiques les contenant et utilisations |
-
2000
- 2000-04-07 JP JP2000107028A patent/JP4780429B2/ja not_active Expired - Lifetime
-
2001
- 2001-04-05 DK DK01919789T patent/DK1273299T3/da active
- 2001-04-05 ES ES01919789T patent/ES2250374T3/es not_active Expired - Lifetime
- 2001-04-05 CN CNB018106498A patent/CN1279914C/zh not_active Expired - Fee Related
- 2001-04-05 NZ NZ521733A patent/NZ521733A/en unknown
- 2001-04-05 RU RU2002126553/15A patent/RU2275914C2/ru active
- 2001-04-05 WO PCT/JP2001/002951 patent/WO2001076605A1/ja active IP Right Grant
- 2001-04-05 HU HU0301124A patent/HUP0301124A2/hu unknown
- 2001-04-05 BR BR0109847-0A patent/BR0109847A/pt not_active Application Discontinuation
- 2001-04-05 AU AU46839/01A patent/AU778783B2/en not_active Ceased
- 2001-04-05 CA CA002405429A patent/CA2405429C/en not_active Expired - Fee Related
- 2001-04-05 DE DE60114171T patent/DE60114171T2/de not_active Expired - Fee Related
- 2001-04-05 AT AT01919789T patent/ATE306925T1/de not_active IP Right Cessation
- 2001-04-05 KR KR1020027013331A patent/KR100740393B1/ko not_active IP Right Cessation
- 2001-04-05 EP EP01919789A patent/EP1273299B1/en not_active Expired - Lifetime
- 2001-04-06 TW TW090108343A patent/TWI239842B/zh not_active IP Right Cessation
-
2002
- 2002-10-03 ZA ZA200207960A patent/ZA200207960B/en unknown
-
2003
- 2003-12-05 HK HK03108884A patent/HK1056510A1/xx not_active IP Right Cessation
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH03176413A (ja) * | 1989-12-05 | 1991-07-31 | Ichimaru Pharcos Co Ltd | 植物由来抽出成分からなるフケ菌発育阻害剤を含有する皮膚・頭皮・頭髪用化粧料 |
| JPH09188620A (ja) * | 1996-01-05 | 1997-07-22 | Taisho Pharmaceut Co Ltd | ヒノキチオール含有組成物 |
| JPH11349451A (ja) * | 1998-06-08 | 1999-12-21 | Taisho Pharmaceut Co Ltd | 育毛剤 |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8026238B2 (en) | 1997-10-17 | 2011-09-27 | Stiefel Research Australia, Pty Ltd | Topical antifungal composition |
| US8586066B2 (en) | 1997-10-17 | 2013-11-19 | Delcor Asset Corporation | Topical antifungal composition |
| US6946120B2 (en) | 1998-04-22 | 2005-09-20 | Connetics Australia Pty. Ltd. | Pharmaceutical composition |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2001288090A (ja) | 2001-10-16 |
| AU778783B2 (en) | 2004-12-23 |
| CN1279914C (zh) | 2006-10-18 |
| NZ521733A (en) | 2003-08-29 |
| EP1273299A1 (en) | 2003-01-08 |
| JP4780429B2 (ja) | 2011-09-28 |
| KR20020087126A (ko) | 2002-11-21 |
| DE60114171D1 (de) | 2006-03-02 |
| HUP0301124A2 (hu) | 2003-08-28 |
| EP1273299A4 (en) | 2003-05-14 |
| ATE306925T1 (de) | 2005-11-15 |
| TWI239842B (en) | 2005-09-21 |
| CA2405429A1 (en) | 2001-10-18 |
| BR0109847A (pt) | 2003-06-24 |
| KR100740393B1 (ko) | 2007-07-16 |
| DK1273299T3 (da) | 2006-02-06 |
| AU4683901A (en) | 2001-10-23 |
| CA2405429C (en) | 2007-09-04 |
| CN1431903A (zh) | 2003-07-23 |
| EP1273299B1 (en) | 2005-10-19 |
| ZA200207960B (en) | 2004-01-27 |
| RU2002126553A (ru) | 2004-03-20 |
| HK1056510A1 (en) | 2004-02-20 |
| RU2275914C2 (ru) | 2006-05-10 |
| ES2250374T3 (es) | 2006-04-16 |
| DE60114171T2 (de) | 2006-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2001076605A1 (fr) | Preparations a base de minoxidil | |
| JP5171947B2 (ja) | コエンザイムｑ１０のナノ−エマルジョン組成物 | |
| KR101790809B1 (ko) | 액체 구강용 조성물 및 그 제조 방법 | |
| DE69933518T2 (de) | Stabile flüssige zusammensetzungen von kalzium-ascorbat und verfahren zu ihrer herstellung und verwendung | |
| JP2010043031A (ja) | 液体口腔用組成物 | |
| JP4796260B2 (ja) | ミノキシジル含有製剤 | |
| JP2822093B2 (ja) | Ｗ／ｏ／ｗ型乳化化粧料 | |
| JP2557557B2 (ja) | ピロキシカム含有局所投与用医薬組成物 | |
| JP2013095691A (ja) | 皮膚外用剤 | |
| JP2013047206A (ja) | 紫外線吸収剤を含有する微細エマルション組成物並びに化粧料 | |
| KR100297347B1 (ko) | 안정화된l-아스코르빈산을함유하는유중수형에멀젼화장료조성물및그의제조방법 | |
| US20070077261A1 (en) | Compositions and method for enhancing the solubility of ascorbic acid using solubilization enhancers | |
| JPH11246513A (ja) | アズレン水性液剤 | |
| JP2007099629A (ja) | 美白用組成物 | |
| JP4872153B2 (ja) | 液体組成物 | |
| JP4137016B2 (ja) | 乳化型皮膚外用剤 | |
| US20170087078A1 (en) | Cosmetic composition containing 3-o-alkyl-l-ascorbic acid or salt thereof | |
| JP5360610B2 (ja) | ミノキシジル含有製剤 | |
| JP2004051511A (ja) | うがい薬 | |
| JP4545271B2 (ja) | 歯磨剤組成物 | |
| JP4336271B2 (ja) | ヨーグルト状の外観を持つ乳化型皮膚外用剤 | |
| JP3313148B2 (ja) | 皮膚外用剤 | |
| JP2007001965A (ja) | 乳化組成物およびそれを含有した化粧料 | |
| JPWO2007135774A1 (ja) | 生薬配合経口液剤組成物 | |
| JP6543945B2 (ja) | 乳化組成物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| WWE | Wipo information: entry into national phase |
Ref document number: 46839/01 Country of ref document: AU |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 521733 Country of ref document: NZ |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2002/07960 Country of ref document: ZA Ref document number: 200207960 Country of ref document: ZA |
|
| ENP | Entry into the national phase |
Ref document number: 2002 2002126553 Country of ref document: RU Kind code of ref document: A |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2001919789 Country of ref document: EP Ref document number: 10240856 Country of ref document: US Ref document number: 1020027013331 Country of ref document: KR |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2405429 Country of ref document: CA |
|
| WWP | Wipo information: published in national office |
Ref document number: 1020027013331 Country of ref document: KR |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 018106498 Country of ref document: CN |
|
| WWP | Wipo information: published in national office |
Ref document number: 2001919789 Country of ref document: EP |
|
| WWP | Wipo information: published in national office |
Ref document number: 521733 Country of ref document: NZ |
|
| WWG | Wipo information: grant in national office |
Ref document number: 521733 Country of ref document: NZ |
|
| WWG | Wipo information: grant in national office |
Ref document number: 46839/01 Country of ref document: AU |
|
| WWG | Wipo information: grant in national office |
Ref document number: 2001919789 Country of ref document: EP |